Immunoscintigraphy of Small-Cell Lung Cancer with Monoclonal Antibody 123C3
Author Information
Author(s): HB Kwal, J Wesseling, AHM Verhoeven, N van Zandwijk, J Hilkens
Primary Institution: The Netherlands Cancer Institute
Hypothesis
The study investigates whether internalisation of monoclonal antibodies can improve tumour uptake in small-cell lung cancer.
Conclusion
The internalisation of radiolabelled monoclonal antibody 123C3 leads to higher accumulation and retention of radioactivity in tumour tissue compared to other antibodies.
Supporting Evidence
- MAb 123C3 showed a higher tumour uptake than MAbs 123A8 and MOCl91.
- Internalisation of MAb 123C3 was confirmed by various imaging techniques.
- The tumour to blood ratio for MAb 123C3 was significantly higher than for the other MAbs.
Takeaway
Researchers found that a special antibody can get inside cancer cells better than others, helping doctors see the cancer more clearly in scans.
Methodology
The study used a Balb/c nu/nu mouse model to evaluate the efficacy of three monoclonal antibodies for immunoscintigraphy of small-cell lung cancer xenografts.
Limitations
The study does not address potential side effects of the antibodies in human tissues.
Participant Demographics
Balb/c nu/nu mice were used in the study.
Statistical Information
P-Value
0.04
Statistical Significance
p=0.04
Want to read the original?
Access the complete publication on the publisher's website